Research Article
Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors
Figure 4
Kaplan–Meier survival curve (in years) showing no significant difference between the RT and non-RT groups in the first supplementary analysis (propensity score-matched analyses). RT, radiotherapy.